Skip to main content
Erschienen in: Supportive Care in Cancer 9/2007

01.09.2007 | Original Article

Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer

verfasst von: Digant Gupta, Christopher G. Lis, James F. Grutsch

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

Cancer and its treatment often lead to financial difficulty in patients with advanced cancer. The goal of this study was to investigate the relationship between perceived cancer-related financial difficulty and patient satisfaction with quality of life (QoL) in advanced cancer.

Materials and methods

A case series of 954 cancer patients treated at Cancer Treatment Centers of America, a private tertiary care oncology facility in the USA, was investigated. Perceived financial difficulty was measured using the QLQ-C30 financial difficulty subscale. Patient satisfaction with QoL was measured using the Ferrans and Powers Quality of Life Index (QLI). The relationship between perceived financial difficulty and QLI was evaluated using multivariate analysis of variance and multiple regression analysis.

Results

Of 954 patients, 579 were women and 375 were men, with the median age at presentation of 56 years (range 20–90 years). Sixty-six percent did not respond to prior treatment. Most common cancers were breast (26%), colorectal (19%), and lung (16%). Two hundred ninety-six (31%) patients perceived their financial condition as poor. Every 10-year increase in current age was significantly associated with a decline in all QLI subscales except for family subscale. Newly diagnosed patients had significantly better QLI scores for all subscales as compared to those who did not respond to definitive treatment elsewhere before coming to our hospital. After controlling for the effects of age and treatment history, every 10-unit increase in perceived financial difficulty score was statistically significantly associated with 0.52, 0.36, 0.32, 0.24, and 0.40 unit decline in QLI health/physical, social/economic, psychological/spiritual, family, and overall function score, respectively.

Conclusions

We found that perceived financial difficulty is strongly correlated with patient satisfaction with QoL in advanced cancer. These findings indicate a need for the providers of cancer care to be aware that nonclinical factors such as perceived financial difficulty can have an important bearing on QoL of cancer patients.
Literatur
1.
Zurück zum Zitat Guidry JJ, Aday LA, Zhang D, Winn RJ (1998) Cost considerations as potential barriers to cancer treatment. Cancer Pract 6(3):182–187PubMedCrossRef Guidry JJ, Aday LA, Zhang D, Winn RJ (1998) Cost considerations as potential barriers to cancer treatment. Cancer Pract 6(3):182–187PubMedCrossRef
2.
Zurück zum Zitat Arozullah AM, Calhoun EA, Wolf M et al (2004) The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2(3):271–278PubMed Arozullah AM, Calhoun EA, Wolf M et al (2004) The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2(3):271–278PubMed
3.
Zurück zum Zitat Stommel M, Given CW, Given BA (1993) The cost of cancer home care to families. Cancer 71(5):1867–1874PubMedCrossRef Stommel M, Given CW, Given BA (1993) The cost of cancer home care to families. Cancer 71(5):1867–1874PubMedCrossRef
4.
Zurück zum Zitat Hayman JA, Langa KM, Kabeto MU et al (2001) Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19(13):3219–3225PubMed Hayman JA, Langa KM, Kabeto MU et al (2001) Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 19(13):3219–3225PubMed
5.
Zurück zum Zitat Longo CJ, Fitch M, Deber RB, Williams AP (2006) Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer Longo CJ, Fitch M, Deber RB, Williams AP (2006) Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer
6.
Zurück zum Zitat Paramore LC, Thomas SK, Knopf KB et al (2006) Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 6(1):52–58PubMedCrossRef Paramore LC, Thomas SK, Knopf KB et al (2006) Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer. Clin Colorectal Cancer 6(1):52–58PubMedCrossRef
7.
Zurück zum Zitat Houts PS, Lipton A, Harvey HA et al (1984) Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer 53(11):2388–2392PubMedCrossRef Houts PS, Lipton A, Harvey HA et al (1984) Nonmedical costs to patients and their families associated with outpatient chemotherapy. Cancer 53(11):2388–2392PubMedCrossRef
8.
Zurück zum Zitat Langa KM, Fendrick AM, Chernew ME et al (2004) Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 7(2):186–194PubMedCrossRef Langa KM, Fendrick AM, Chernew ME et al (2004) Out-of-pocket health-care expenditures among older Americans with cancer. Value Health 7(2):186–194PubMedCrossRef
9.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
10.
Zurück zum Zitat Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient–observer agreement. J Clin Epidemiol 50(4):441–450PubMedCrossRef Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient–observer agreement. J Clin Epidemiol 50(4):441–450PubMedCrossRef
11.
Zurück zum Zitat Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. J Clin Oncol 13(5):1249–1254PubMed Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. J Clin Oncol 13(5):1249–1254PubMed
12.
Zurück zum Zitat Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed
13.
Zurück zum Zitat Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed
14.
Zurück zum Zitat Ferrans CE, Powers MJ (1992) Psychometric assessment of the quality of life index. Res Nurs Health 15(1):29–38PubMedCrossRef Ferrans CE, Powers MJ (1992) Psychometric assessment of the quality of life index. Res Nurs Health 15(1):29–38PubMedCrossRef
15.
Zurück zum Zitat Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed
16.
Zurück zum Zitat Yun YH, Rhee YS, Kang IO et al (2005) Economic burdens and quality of life of family caregivers of cancer patients. Oncology 68(2–3):107–114PubMedCrossRef Yun YH, Rhee YS, Kang IO et al (2005) Economic burdens and quality of life of family caregivers of cancer patients. Oncology 68(2–3):107–114PubMedCrossRef
17.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed
Metadaten
Titel
Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer
verfasst von
Digant Gupta
Christopher G. Lis
James F. Grutsch
Publikationsdatum
01.09.2007
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0214-2

Weitere Artikel der Ausgabe 9/2007

Supportive Care in Cancer 9/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.